{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:22:24Z","timestamp":1794856944984,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2012R1A5A2048183"],"award-info":[{"award-number":["NRF-2012R1A5A2048183"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:p>Multifunctional signal transducer and activator of transcription (STAT) proteins play important roles in cancer. Here, we have shown that STAT6 is epigenetically silenced in some cases of malignant glioblastoma, which facilitates cancer cell survival in a hypoxic microenvironment. This downregulation results from hypermethylation of CpG islands within the <jats:italic>STAT6<\/jats:italic> promoter by DNA methyltransferases. STAT6 interacts with Rheb under hypoxia and inhibits mTOR\/S6K\/S6 signaling, in turn, inducing increased HIF-1\u03b1 translation. STAT6 silencing and consequent tumor-promoting effects are additionally observed in glioma stem-like cells (GSC). Despite recent advances in cancer treatment, survival rates have shown little improvement. This is particularly true in the case of glioma, where multimodal treatment and precision medicine is needed. Our study supports the application of epigenetic restoration of STAT6 with the aid of DNA methyltransferase inhibitors, such as 5-aza-2-deoxycytidine, for treatment of STAT6-silenced gliomas.<\/jats:p>","DOI":"10.1186\/s40478-019-0798-z","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T08:04:01Z","timestamp":1568707441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic downregulation of STAT6 increases HIF-1\u03b1 expression via mTOR\/S6K\/S6, leading to enhanced hypoxic viability of glioma cells"],"prefix":"10.1186","volume":"7","author":[{"given":"Soo Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hyuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-hye","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1354-1223","authenticated-orcid":false,"given":"Ilo","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,17]]},"reference":[{"key":"798_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","volume":"67","author":"N Ahuja","year":"2016","unstructured":"Ahuja N, Sharma AR, Baylin SB (2016) Epigenetic therapeutics: a new weapon in the war against Cancer. Annu Rev Med 67:73\u201389. \n                    https:\/\/doi.org\/10.1146\/annurev-med-111314-035900","journal-title":"Annu Rev Med"},{"key":"798_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nature05029","volume":"442","author":"R Bernardi","year":"2006","unstructured":"Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, Cordon-Cardo C, Simon MC, Rafii S, Pandolfi PP (2006) PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442:779\u2013785. \n                    https:\/\/doi.org\/10.1038\/nature05029","journal-title":"Nature"},{"key":"798_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1541-7786.MCR-07-2180","volume":"6","author":"EC Brantley","year":"2008","unstructured":"Brantley EC, Benveniste EN (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6:675\u2013684. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-2180","journal-title":"Mol Cancer Res"},{"key":"798_CR4","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WG Jr (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 18:2893\u20132904. \n                    https:\/\/doi.org\/10.1101\/gad.1256804","journal-title":"Genes Dev"},{"key":"798_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","volume":"147","author":"H Chen","year":"2011","unstructured":"Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y et al (2011) Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436\u2013446. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.09.022","journal-title":"Cell"},{"key":"798_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s11064-008-9864-9","volume":"34","author":"L Chen","year":"2009","unstructured":"Chen L, Feng P, Li S, Long D, Cheng J, Lu Y, Zhou D (2009) Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide. Neurochem Res 34:984\u2013990. \n                    https:\/\/doi.org\/10.1007\/s11064-008-9864-9","journal-title":"Neurochem Res"},{"key":"798_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A et al (2015) Inhibiting DNA methylation causes an interferon response in Cancer via dsRNA including endogenous retroviruses. Cell 162:974\u2013986. \n                    https:\/\/doi.org\/10.1016\/j.cell.2015.07.011","journal-title":"Cell"},{"key":"798_CR8","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0809136105","volume":"105","author":"AY Choo","year":"2008","unstructured":"Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 105:17414\u201317419. \n                    https:\/\/doi.org\/10.1073\/pnas.0809136105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR9","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1073\/pnas.122236099","volume":"99","author":"AP Costa-Pereira","year":"2002","unstructured":"Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is\u2019harc H, Gesualdo I, Newman SJ, Kerr IM, Poli V (2002) Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A 99:8043\u20138047. \n                    https:\/\/doi.org\/10.1073\/pnas.122236099","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR10","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR (2015) mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34:2239\u20132250. \n                    https:\/\/doi.org\/10.1038\/onc.2014.164","journal-title":"Oncogene"},{"key":"798_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/1471-2164-11-701","volume":"11","author":"A Etcheverry","year":"2010","unstructured":"Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P et al (2010) DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 11:701. \n                    https:\/\/doi.org\/10.1186\/1471-2164-11-701","journal-title":"BMC Genomics"},{"key":"798_CR12","first-page":"793","volume":"30","author":"S Fujiwara","year":"2007","unstructured":"Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T (2007) Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30:793\u2013802","journal-title":"Int J Oncol"},{"key":"798_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL (2002) Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2:38\u201347. \n                    https:\/\/doi.org\/10.1038\/nrc704","journal-title":"Nat Rev Cancer"},{"key":"798_CR14","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","volume":"8","author":"JM Heddleston","year":"2009","unstructured":"Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274\u20133284. \n                    https:\/\/doi.org\/10.4161\/cc.8.20.9701","journal-title":"Cell Cycle"},{"issue":"Suppl","key":"798_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245\u2013254. \n                    https:\/\/doi.org\/10.1038\/ng1089","journal-title":"Nat Genet"},{"key":"798_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","volume":"92","author":"RL Jensen","year":"2009","unstructured":"Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neuro-Oncol 92:317\u2013335. \n                    https:\/\/doi.org\/10.1007\/s11060-009-9827-2","journal-title":"J Neuro-Oncol"},{"key":"798_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484\u2013492. \n                    https:\/\/doi.org\/10.1038\/nrg3230","journal-title":"Nat Rev Genet"},{"key":"798_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","volume":"1","author":"RA Juergens","year":"2011","unstructured":"Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, Sebree R, Rodgers K, Hooker CM, Franco N et al (2011) Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 1:598\u2013607. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0214","journal-title":"Cancer Discov"},{"key":"798_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/86507","volume":"7","author":"MS Kim","year":"2001","unstructured":"Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY et al (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7:437\u2013443. \n                    https:\/\/doi.org\/10.1038\/86507","journal-title":"Nat Med"},{"key":"798_CR20","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/leu.2014.89","volume":"28","author":"M Kontro","year":"2014","unstructured":"Kontro M, Kuusanmaki H, Eldfors S, Burmeister T, Andersson EI, Bruserud O, Brummendorf TH, Edgren H, Gjertsen BT, Itala-Remes M et al (2014) Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia. Leukemia 28:1738\u20131742. \n                    https:\/\/doi.org\/10.1038\/leu.2014.89","journal-title":"Leukemia"},{"key":"798_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","volume":"366","author":"HL Koskela","year":"2012","unstructured":"Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI, Lagstrom S, Clemente MJ, Olson T, Jalkanen SE et al (2012) Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 366:1905\u20131913. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1114885","journal-title":"N Engl J Med"},{"key":"798_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN (2015) Cancer stem cells in glioblastoma. Genes Dev 29:1203\u20131217. \n                    https:\/\/doi.org\/10.1101\/gad.261982.115","journal-title":"Genes Dev"},{"key":"798_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/onc.2008.377","volume":"28","author":"SH Lee","year":"2009","unstructured":"Lee SH, Kim J, Kim WH, Lee YM (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28:184\u2013194. \n                    https:\/\/doi.org\/10.1038\/onc.2008.377","journal-title":"Oncogene"},{"key":"798_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19:373\u2013379. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001","journal-title":"Cell Metab"},{"key":"798_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, RE ML et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501\u2013513. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2009.03.018","journal-title":"Cancer Cell"},{"key":"798_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2008.08.011","volume":"273","author":"QC Liang","year":"2009","unstructured":"Liang QC, Xiong H, Zhao ZW, Jia D, Li WX, Qin HZ, Deng JP, Gao L, Zhang H, Gao GD (2009) Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells. Cancer Lett 273:164\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2008.08.011","journal-title":"Cancer Lett"},{"key":"798_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nn.4190","volume":"19","author":"SC Mack","year":"2016","unstructured":"Mack SC, Hubert CG, Miller TE, Taylor MD, Rich JN (2016) An epigenetic gateway to brain tumor cell identity. Nat Neurosci 19:10\u201319. \n                    https:\/\/doi.org\/10.1038\/nn.4190","journal-title":"Nat Neurosci"},{"key":"798_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/onc.2013.100","volume":"33","author":"Y Martineau","year":"2014","unstructured":"Martineau Y, Azar R, Muller D, Lasfargues C, El Khawand S, Anesia R, Pelletier J, Bousquet C, Pyronnet S (2014) Pancreatic tumours escape from translational control through 4E-BP1 loss. Oncogene 33:1367\u20131374. \n                    https:\/\/doi.org\/10.1038\/onc.2013.100","journal-title":"Oncogene"},{"key":"798_CR29","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1128\/MCB.23.9.3265-3273.2003","volume":"23","author":"VT Mihaylova","year":"2003","unstructured":"Mihaylova VT, Bindra RS, Yuan J, Campisi D, Narayanan L, Jensen R, Giordano F, Johnson RS, Rockwell S, Glazer PM (2003) Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 23:3265\u20133273","journal-title":"Mol Cell Biol"},{"key":"798_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G Miklossy","year":"2013","unstructured":"Miklossy G, Hilliard TS, Turkson J (2013) Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov 12:611\u2013629. \n                    https:\/\/doi.org\/10.1038\/nrd4088","journal-title":"Nat Rev Drug Discov"},{"key":"798_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cell.2016.03.031","volume":"165","author":"AJ Minn","year":"2016","unstructured":"Minn AJ, Wherry EJ (2016) Combination Cancer therapies with immune checkpoint blockade: convergence on interferon signaling. Cell 165:272\u2013275. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.03.031","journal-title":"Cell"},{"key":"798_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1083\/jcb.200503021","volume":"172","author":"DC Ng","year":"2006","unstructured":"Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X (2006) Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 172:245\u2013257. \n                    https:\/\/doi.org\/10.1083\/jcb.200503021","journal-title":"J Cell Biol"},{"key":"798_CR33","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/leu.2014.200","volume":"28","author":"A Nicolae","year":"2014","unstructured":"Nicolae A, Xi L, Pittaluga S, Abdullaev Z, Pack SD, Chen J, Waldmann TA, Jaffe ES, Raffeld M (2014) Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas. Leukemia 28:2244\u20132248. \n                    https:\/\/doi.org\/10.1038\/leu.2014.200","journal-title":"Leukemia"},{"key":"798_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510\u2013522. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2010.03.017","journal-title":"Cancer Cell"},{"key":"798_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-015-1810-5","volume":"123","author":"MA Patel","year":"2015","unstructured":"Patel MA, Pardoll DM (2015) Concepts of immunotherapy for glioma. J Neuro-Oncol 123:323\u2013330. \n                    https:\/\/doi.org\/10.1007\/s11060-015-1810-5","journal-title":"J Neuro-Oncol"},{"key":"798_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28:1057\u20131068. \n                    https:\/\/doi.org\/10.1038\/nbt.1685","journal-title":"Nat Biotechnol"},{"key":"798_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/cdd.2011.95","volume":"19","author":"L Qiang","year":"2012","unstructured":"Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang YJ, Zhao L, Chen FH, Wang XT, You QD et al (2012) HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating notch signaling pathway. Cell Death Differ 19:284\u2013294. \n                    https:\/\/doi.org\/10.1038\/cdd.2011.95","journal-title":"Cell Death Differ"},{"key":"798_CR38","doi-asserted-by":"publisher","first-page":"41679","DOI":"10.1074\/jbc.M406413200","volume":"279","author":"Y Qing","year":"2004","unstructured":"Qing Y, Stark GR (2004) Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279:41679\u201341685. \n                    https:\/\/doi.org\/10.1074\/jbc.M406413200","journal-title":"J Biol Chem"},{"key":"798_CR39","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1158\/0008-5472.CAN-04-3592","volume":"65","author":"SO Rahaman","year":"2005","unstructured":"Rahaman SO, Vogelbaum MA, Haque SJ (2005) Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2. Cancer Res 65:2956\u20132963. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3592","journal-title":"Cancer Res"},{"key":"798_CR40","doi-asserted-by":"publisher","first-page":"e0162105","DOI":"10.1371\/journal.pone.0162105","volume":"11","author":"C Riccadonna","year":"2016","unstructured":"Riccadonna C, Yacoub Maroun C, Vuillefroy de Silly R, Boehler M, Calvo Tardon M, Jueliger S, Taverna P, Barba L, Marinari E, Pellegatta S et al (2016) Decitabine treatment of glioma-initiating cells enhances immune recognition and killing. PLoS One 11:e0162105. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0162105","journal-title":"PLoS One"},{"key":"798_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"GL Semenza","year":"2012","unstructured":"Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33:207\u2013214. \n                    https:\/\/doi.org\/10.1016\/j.tips.2012.01.005","journal-title":"Trends Pharmacol Sci"},{"key":"798_CR42","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1073\/pnas.041588198","volume":"98","author":"Y Shen","year":"2001","unstructured":"Shen Y, Devgan G, Darnell JE Jr, Bromberg JF (2001) Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 98:1543\u20131548. \n                    https:\/\/doi.org\/10.1073\/pnas.041588198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR43","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1038\/onc.2009.252","volume":"28","author":"A Soeda","year":"2009","unstructured":"Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949\u20133959. \n                    https:\/\/doi.org\/10.1038\/onc.2009.252","journal-title":"Oncogene"},{"key":"798_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1365-2990.2002.00391.x","volume":"28","author":"KL Sondergaard","year":"2002","unstructured":"Sondergaard KL, Hilton DA, Penney M, Ollerenshaw M, Demaine AG (2002) Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma. Neuropathol Appl Neurobiol 28:210\u2013217","journal-title":"Neuropathol Appl Neurobiol"},{"key":"798_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"GR Stark","year":"2012","unstructured":"Stark GR, Darnell JE Jr (2012) The JAK-STAT pathway at twenty. Immunity 36:503\u2013514. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2012.03.013","journal-title":"Immunity"},{"key":"798_CR46","doi-asserted-by":"publisher","first-page":"14192","DOI":"10.1074\/jbc.M111.323899","volume":"287","author":"OA Timofeeva","year":"2012","unstructured":"Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L et al (2012) Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 287:14192\u201314200. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.323899","journal-title":"J Biol Chem"},{"key":"798_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ccr.2011.12.029","volume":"21","author":"HC Tsai","year":"2012","unstructured":"Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E et al (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21:430\u2013446. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2011.12.029","journal-title":"Cancer Cell"},{"key":"798_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A et al (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793\u2013797. \n                    https:\/\/doi.org\/10.1126\/science.1164551","journal-title":"Science"},{"key":"798_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","volume":"10","author":"W Wick","year":"2014","unstructured":"Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G (2014) MGMT testing--the challenges for biomarker-based glioma treatment. Nat Rev Neurol 10:372\u2013385. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2014.100","journal-title":"Nat Rev Neurol"},{"key":"798_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","volume":"33","author":"SR Woo","year":"2015","unstructured":"Woo SR, Corrales L, Gajewski TF (2015) Innate immune recognition of cancer. Annu Rev Immunol 33:445\u2013474. \n                    https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112043","journal-title":"Annu Rev Immunol"},{"key":"798_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jnci\/djj020","volume":"98","author":"S Xi","year":"2006","unstructured":"Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J et al (2006) Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 98:181\u2013189. \n                    https:\/\/doi.org\/10.1093\/jnci\/djj020","journal-title":"J Natl Cancer Inst"},{"key":"798_CR52","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","volume":"88","author":"D Zagzag","year":"2000","unstructured":"Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606\u20132618","journal-title":"Cancer"},{"key":"798_CR53","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/nm1659","volume":"13","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Wang HY, Liu X, Wasik MA (2007) STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nat Med 13:1341\u20131348. \n                    https:\/\/doi.org\/10.1038\/nm1659","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0798-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T23:11:04Z","timestamp":1600211464000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0798-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0798-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,17]]},"assertion":[{"value":"14 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}